NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,000 | -16.7% | 9,575 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +20.0% | 9,575 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -58.3% | 9,575 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | -33.3% | 9,575 | +5.8% | 0.00% | -100.0% |
| Q3 2019 | $18,000 | +157.1% | 9,050 | +196.7% | 0.00% | – |
| Q2 2019 | $7,000 | – | 3,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |